These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1717142)

  • 21. Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown.
    Puca R; Nardinocchi L; Gal H; Rechavi G; Amariglio N; Domany E; Notterman DA; Scarsella M; Leonetti C; Sacchi A; Blandino G; Givol D; D'Orazi G
    Cancer Res; 2008 May; 68(10):3707-14. PubMed ID: 18483253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels.
    Ronen D; Schwartz D; Teitz Y; Goldfinger N; Rotter V
    Cell Growth Differ; 1996 Jan; 7(1):21-30. PubMed ID: 8788030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines.
    Li CY; Nagasawa H; Dahlberg WK; Little JB
    Oncogene; 1995 Nov; 11(9):1885-92. PubMed ID: 7478618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL; Ling YF; Lai MD
    Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53.
    Salewski H; Bayer TA; Eidhoff U; Preuss U; Weggen S; Scheidtmann KH
    Cancer Res; 1999 Apr; 59(8):1980-6. PubMed ID: 10213510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
    Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD
    Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type.
    Thomas S; Reisman D
    Cancer Lett; 2006 Aug; 240(1):48-59. PubMed ID: 16236433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control.
    Pollock R; Lang A; Ge T; Sun D; Tan M; Yu D
    Clin Cancer Res; 1998 Aug; 4(8):1985-94. PubMed ID: 9717829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 is a regulator of macrophage differentiation.
    Matas D; Milyavsky M; Shats I; Nissim L; Goldfinger N; Rotter V
    Cell Death Differ; 2004 Apr; 11(4):458-67. PubMed ID: 14713961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo.
    Rubio R; García-Castro J; Gutiérrez-Aranda I; Paramio J; Santos M; Catalina P; Leone PE; Menendez P; Rodríguez R
    Cancer Res; 2010 May; 70(10):4185-94. PubMed ID: 20442289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes.
    Willis A; Jung EJ; Wakefield T; Chen X
    Oncogene; 2004 Mar; 23(13):2330-8. PubMed ID: 14743206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells.
    Katayose D; Gudas J; Nguyen H; Srivastava S; Cowan KH; Seth P
    Clin Cancer Res; 1995 Aug; 1(8):889-97. PubMed ID: 9816059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of bone morphogenetic protein expression during osteoblast differentiation to wild type p53.
    Chandar N; Swindle J; Szajkovics A; Kolman K
    J Orthop Res; 2005 Nov; 23(6):1345-53. PubMed ID: 15994055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhibitory effect of p53 with deletion of c-terminal 356 - 393 amino acids on malignant phenotype of human lung cancer cell line].
    Wang H; Li JZ; Lai BT; Yang XH; Zhang CY; Yue WT; Zhan XP
    Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):527-30. PubMed ID: 14690553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
    Zhang AL; Russell PJ; Knittel T; Milross C
    Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
    Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
    Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated expression of ribosomal protein genes L37, RPP-1, and S2 in the presence of mutant p53.
    Loging WT; Reisman D
    Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):1011-6. PubMed ID: 10566557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.